Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas-Reference-Cited by-同舟云学术

Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas

Published:2020-09-03 Issue:9 Volume:15 Page:e0238238
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Minea Radu O.^ORCID,Duc Tuan Cao^ORCID,Swenson Stephen D.,Cho Hee-Yeon,Huang Mickey,Hartman Hannah,Hofman Florence M.,Schönthal Axel H.,Chen Thomas C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Newly Diagnosed Glioblastoma: A Review on Clinical Management;R.V. Lukas;Oncology (Williston Park),2019

2. Survival in glioblastoma: a review on the impact of treatment modalities;P.D. Delgado-Lopez;Clin Transl Oncol,2016

3. Therapy for glioblastoma: is it working?;E.D. Zanders;Drug Discov Today,2019

4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;R. Stupp;N Engl J Med,2005

5. Temozolomide resistance in glioblastoma multiforme;S.Y. Lee;Genes Dis,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide;Journal of Medicinal Chemistry;2024-02-12

2. NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastoma;Neuro-Oncology Advances;2024-01-01

3. Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models;Cancers;2023-09-08

4. A systematic review on the development of radiosensitizers, with cancer selectivity, for radiotherapy using ionizing radiation;AIMS Bioengineering;2023

5. Terpenes: A hope for glioblastoma patients;New Insights Into Glioblastoma;2023